Precision Pancreatic Cancer Treatments
This is a Birmingham news story, published by ScienceDaily, that relates primarily to Dr Shivan Sivakumar news.
Birmingham news
For more Birmingham news, you can click here:
more Birmingham newsDr Shivan Sivakumar news
For more Dr Shivan Sivakumar news, you can click here:
more Dr Shivan Sivakumar newsbiology news
For more biology news, you can click here:
more biology newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
immunosuppressive macrophages. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest available pancreatic cancer datasets news, Pancreatic cancer news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pancreatic cancer treatmentScienceDaily
•Science
Science
Pancreatic cancer immune map provides clues for precision treatment targeting

77% Informative
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies.
The findings suggest that some tumour cells are more likely to be infiltrated by T cell treatments, while others had myeloid cell infiltration.
This means that macrophages could be suitable for future immunotherapeutic treatments in some cases.
Birmingham is running the mRNA vaccine study for pancreatic cancer to see if this can prevent recurrence in Birmingham and have two further studies imminently opening in this disease.
"Any potential breakthroughs in Pancreatic cancer treatment are therefore so important," says Dr Shivan Sivakumar .
VR Score
86
Informative language
92
Neutral language
34
Article tone
formal
Language
English
Language complexity
77
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links